Journal of Chemotherapy

Papers
(The H4-Index of Journal of Chemotherapy is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Clinical evaluation of camrelizumab combined with transarterial chemoembolization in the interventional therapy of hepatocellular carcinoma with liver cirrhosis70
Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam48
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA231
Innovative sequential therapy in a rare case of refractory Erdheim-Chester disease with bilateral pulmonary involvement30
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer22
Piperacillin/Tazobactam is associated with a higher risk of acute kidney injury compared to cefepime and meropenem21
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae17
Cytofluorimetric study of cerebrospinal fluid at staging of diffuse large B cell lymphoma13
Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis13
Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer12
YAP/TAZ axis was involved in the effects of metformin on breast cancer12
Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database11
0.061599016189575